Home Bayer spending $100 million on Berkeley hemophilia drug facility
 

Keywords :   


Bayer spending $100 million on Berkeley hemophilia drug facility

2015-04-30 00:03:51| Chemicals - Topix.net

Bayer HealthCare is spending $100 million over the next two years building a product testing facility here for a new hemophilia drug, a project that will create 325,000 hours of construction work, officials said during a news conference Wednesday. Bayer's Berkeley campus, which spans three city blocks on 7th Street between Dwight Way and Grayson Street, manufactures a drug for people with hemophilia A called Kogenate.

Tags: million drug facility spending

Category:Chemicals

Latest from this category

All news

23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »